NCT06054464 - A Study to Investigate the Effects of Acid Reducing Agents on Pharmacokinetics of PC14586 in Healthy Participants | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 19, 2023

Primary Completion Date

November 3, 2023

Study Completion Date

February 6, 2024

Conditions

Healthy Volunteers

Interventions

DRUG

PC14586

Part 1 and Part 2: Single, oral dose of PC14586 on day 1 and single, oral dose of PC14586 on day 14.

DRUG

Rabeprazole

Part 1: Daily oral dose of rabeprazole on days 11-14.

DRUG

Famotidine

Part 2: Twice daily oral dose of famotidine on days 11-13. Single, oral dose of famotidine on day 14.

Trial Locations (1)

Parexel International, Baltimore